The U.S. intracranial pressure monitoring devices market is expected to witness significant growth in the forecast period due to the increasing prevalence of neurological disorders and traumatic brain injuries. The rising adoption of minimally invasive procedures and technological advancements in monitoring devices are also driving market growth.
Two major growth drivers in the U.S. intracranial pressure monitoring devices market include the growing geriatric population and the increasing number of road accidents leading to traumatic brain injuries. These factors are expected to propel the demand for intracranial pressure monitoring devices in the healthcare industry.
Segment Analysis
The U.S. intracranial pressure monitoring devices market can be segmented based on product type, technique, application, and end-user. The product type segment includes intraventricular and subdural monitors, while the technique segment comprises invasive and non-invasive monitoring. The application segment covers traumatic brain injuries, meningitis, and others. Lastly, the end-user segment includes hospitals, specialty clinics, and ambulatory surgical centers.
Competitive Landscape
Key players operating in the U.S. intracranial pressure monitoring devices market include Codman & Shurtleff, Inc., Medtronic plc, Integra LifeSciences Corporation, and Sophysa. These companies are focusing on product innovations, strategic partnerships, and acquisitions to strengthen their market presence and gain a competitive edge. Increasing investments in research and development activities are also expected to drive market competitiveness among key players.